LEUL against its peers Leather Up Limited
Leather Up Limited (LEUL) is set against 5 peers in the LEATHER & TANNERIES sector. By market value it ranks 5 of 6.
LEATHER & TANNERIES peers on one table
| Company | Last close (Rs) | Place in the 52-week range | Market value | Price per rupee earned (12 months) |
|---|---|---|---|---|
| SRVI | 177.51 | 43% | Rs 83.4 bn | 6.57 |
| SGF | 108.27 | 57% | Rs 22.4 bn | 6.78 |
| BATA | 786.66 | 1% | Rs 5.9 bn | — |
| FIL | 297.02 | 42% | Rs 594.0 m | — |
| LEUL (this company) | 82.90 | 79% | Rs 497.4 m | — |
| PAKL | 70.50 | 89% | Rs 239.7 m | — |
Place in the range: 0% is the 52-week low and 100% the high, on closes adjusted for splits and bonus issues. The other companies are those in the same PSX sector that traded in the last 10 sessions. A sector median needs 1 or more companies. As of 13 Nov 2026.
Returns against the index and the sector
LEUL return with dividends by window
| Window | LEUL price | LEUL with dividends | KSE-100 | Sector median |
|---|---|---|---|---|
| 1 month | +19.62% | +19.62% | +7.53% | +0.25%5 companies |
| 3 months | +67.20% | +67.20% | -1.24% | -6.99%5 companies |
| 6 months | +172.79% | +172.79% | +7.41% | -3.90%5 companies |
| Since 1 January | +86.12% | +86.12% | +2.19% | +12.70%5 companies |
| 1 year | +73.43% | +73.43% | +10.72% | +35.64%5 companies |
| 3 years | +806.01% | +806.01% | +213.90% | +173.11%4 companies |
| 5 years | +492.57% | +492.57% | +288.80% | +117.50%3 companies |
Price only: closes adjusted for bonus and rights issues, to the latest price. With dividends: adds cash dividends, not reinvested. The KSE-100 figure reinvests dividends. Source: PSX closes and payout notices.
More on LEUL
- LEUL share price and overview
- Leather & Tanneries sector
- PAKL peers · Pak Leather Crafts Limited
- SGF peers · Service GlobalFootwear Limited
- SRVI peers · Service Industries Limited
- BATA peers · Bata Pakistan Limited
- FIL peers · Fateh Industries Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .